Sign In

Hui Liu

Chief Business Officer & Head of U.S. at Merus N.V. (Nasdaq: MRUS); Board member at Rallybio (Nasdaq: RLYB)

Hui Liu, Ph.D. is a seasoned biopharma executive with 25 years of experience in business development, finance, and strategy who serves as a Board Member at Rallybio.1

Professional Background

Currently, Dr. Liu holds the position of Executive Vice President, Chief Business Officer and Head of US at Merus N.V., a clinical-stage oncology company focused on developing multispecific antibody therapeutics.14

Career History

Prior to joining Merus, Hui Liu had an impressive career trajectory:

  • Global Head of Business Development & Licensing at Novartis Oncology
  • Global Head of Business Development and Licensing for Novartis Vaccines & Diagnostics
  • Held roles of increasing responsibility in business development at Pfizer
  • Worked in investment banking at Citigroup and Goldman Sachs1

Education

Dr. Liu's educational background includes:

  • B.S. in biology from Peking University in Beijing, China
  • M.B.A. in finance from the University of Michigan
  • Ph.D. in molecular biology from the University of Michigan1

Board Appointment

Hui Liu was appointed to Rallybio's Board of Directors in April 2022, alongside Christine A. Nash.23 His extensive experience in the biopharma industry makes him a valuable addition to Rallybio's leadership team.

Highlights

Rallybio Appoints Christine A. Nash and Hui Liu, Ph.D., to Its Board ...

Related Questions

What are Hui Liu's main responsibilities at Rallybio?
How did Hui Liu's career evolve before joining Rallybio?
What are Hui Liu's key achievements in the biopharma industry?
How does Hui Liu's experience at Merus N.V. influence her role at Rallybio?
What are Hui Liu's educational background and qualifications?
Hui Liu
Hui Liu, photo 1
Hui Liu, photo 2
Add to my network

Location

Greater Boston